Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


27.03.2017

2 Brain Res
1 Drugs
2 J Neural Transm (Vienna)
1 J Neurochem
3 J Neurol Neurosurg Psychiatry
2 Lancet Neurol
1 Mov Disord
1 Neurology
1 Neurosci Lett
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Brain Res

  1. CAUQUIL AS, Ory-Magne F, Jardine V, Galitzky M, et al
    Parkinson's patients can rely on perspective cues to perceive 3D space.
    Brain Res. 2017 Mar 18. pii: S0006-8993(17)30125.
    PubMed     Text format     Abstract available

  2. LEE Y, Heo G, Lee KM, Kim AH, et al
    Neuroprotective effects of 2,4-dinitrophenol in an acute model of Parkinson's disease.
    Brain Res. 2017 Mar 17. pii: S0006-8993(17)30133.
    PubMed     Text format     Abstract available


    Drugs

  3. MARKHAM A
    Pimavanserin: First Global Approval.
    Drugs. 2016;76:1053-7.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  4. VERMILYEA SC, Emborg ME
    The role of nonhuman primate models in the development of cell-based therapies for Parkinson's disease.
    J Neural Transm (Vienna). 2017 Mar 22. doi: 10.1007/s00702-017-1708.
    PubMed     Text format     Abstract available

  5. MENDONCA MD, Lampreia T, Miguel R, Caetano A, et al
    Motor and non-motor symptoms in old-age onset Parkinson's disease patients.
    J Neural Transm (Vienna). 2017 Mar 17. doi: 10.1007/s00702-017-1711.
    PubMed     Text format     Abstract available


    J Neurochem

  6. KANNINEN KM, White AR
    Type-I interferons in Parkinson's disease: innate inflammatory response drives fate of neurons in model of degenerative brain disorder: An editorial comment on 'Type-I interferons mediate the neuroinflammatory response and neurotoxicity induced by rot
    J Neurochem. 2017;141:9-11.
    PubMed     Text format     Abstract available


    J Neurol Neurosurg Psychiatry

  7. FIRBANK MJ, Yarnall AJ, Lawson RA, Duncan GW, et al
    Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study.
    J Neurol Neurosurg Psychiatry. 2017;88:310-316.
    PubMed     Text format     Abstract available

  8. ANTONINI A, Barone P, Bonuccelli U, Annoni K, et al
    ICARUS study: prevalence and clinical features of impulse control disorders in Parkinson's disease.
    J Neurol Neurosurg Psychiatry. 2017;88:317-324.
    PubMed     Text format     Abstract available

  9. FFYTCHE DH, Pereira JB, Ballard C, Chaudhuri KR, et al
    Risk factors for early psychosis in PD: insights from the Parkinson's Progression Markers Initiative.
    J Neurol Neurosurg Psychiatry. 2017;88:325-331.
    PubMed     Text format     Abstract available


    Lancet Neurol

  10. SCHRAG A, Weintraub D, Schott JM
    Cognitive decline before diagnosis of Parkinson's disease - Authors' reply.
    Lancet Neurol. 2017;16:262.
    PubMed     Text format    

  11. DARWEESH SK, Koudstaal PJ, Ikram MK, Ikram MA, et al
    Cognitive decline before diagnosis of Parkinson's disease.
    Lancet Neurol. 2017;16:262.
    PubMed     Text format    


    Mov Disord

  12. MARRAS C
    What Would Dr. James Parkinson Think Today III: Measuring Health-Related Quality of Life.
    Mov Disord. 2017;32:364-365.
    PubMed     Text format    


    Neurology

  13. ROCHESTER L, Galna B, Lord S, Yarnall AJ, et al
    Decrease in Abeta42 predicts dopa-resistant gait progression in early Parkinson disease.
    Neurology. 2017 Mar 22. pii: 10.1212/WNL.0000000000003840.
    PubMed     Text format     Abstract available


    Neurosci Lett

  14. DEMETER G, Valalik I, Pajkossy P, Szollosi A, et al
    The effect of deep brain stimulation of the subthalamic nucleus on executive functions: Impaired verbal fluency and intact updating, planning and conflict resolution in Parkinson's disease.
    Neurosci Lett. 2017 Mar 18. pii: S0304-3940(17)30247.
    PubMed     Text format     Abstract available


    PLoS One

  15. WEN M, Zhou B, Chen YH, Ma ZL, et al
    Serum uric acid levels in patients with Parkinson's disease: A meta-analysis.
    PLoS One. 2017;12:e0173731.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: